Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ

[1]  Yun-Jiu Cheng,et al.  Long‐Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer , 2017, Journal of the American Heart Association.

[2]  M. Schmidt,et al.  Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ , 2017, Annals of surgery.

[3]  M. Holmqvist,et al.  A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years , 2016, Acta oncologica.

[4]  E. Hwang,et al.  Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. , 2015, Journal of the National Cancer Institute.

[5]  G. Damiani,et al.  The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. , 2015, Preventive medicine.

[6]  E. Rutgers,et al.  Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast , 2014, Journal of the National Cancer Institute.

[7]  J. Coebergh,et al.  Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. , 2014, Breast.

[8]  S. Schnitt,et al.  Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? , 2013, Journal of the National Cancer Institute.

[9]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[10]  Katherine E Henson,et al.  Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer , 2012, British Journal of Cancer.

[11]  Hans Garmo,et al.  Distribution of coronary artery stenosis after radiation for breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Starr,et al.  Cardiac Morbidity and Mortality in Women with Ductal Carcinoma In Situ of the Breast Treated with Breast Conservation Therapy , 2011, The breast journal.

[13]  P. Hall,et al.  Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[15]  R. Peto,et al.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. , 2010, Journal of the National Cancer Institute. Monographs.

[16]  S. Darby,et al.  Cardiac dose from tangential breast cancer radiotherapy in the year 2006. , 2008, International journal of radiation oncology, biology, physics.

[17]  Andrew Nisbet,et al.  Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. , 2007, International journal of radiation oncology, biology, physics.

[18]  Wei-Ting Hwang,et al.  Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Wei-Ting Hwang,et al.  Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Holmberg,et al.  SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening , 2006, Acta oncologica.

[21]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[22]  R. Peto,et al.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.

[23]  T. Tuttle,et al.  Trends in the treatment of ductal carcinoma in situ of the breast. , 2004, Journal of the National Cancer Institute.

[24]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[25]  J. Houghton.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.

[26]  A. Mielck,et al.  Educational differences in smoking: international comparison , 2000, BMJ : British Medical Journal.

[27]  K. Kerlikowske,et al.  Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. , 2000, Archives of internal medicine.

[28]  J. Peterse,et al.  Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 , 2000, The Lancet.

[29]  M Baum,et al.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[31]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[32]  I. Cohen,et al.  [Postmenopausal estrogen therapy and cardiovascular disease]. , 1991, Harefuah.

[33]  E. B. Butler,et al.  Trends in cardiac mortality in women with ductal carcinoma in situ , 2016, Breast Cancer Research and Treatment.

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.